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ABSTRACT
Through controlling the nuclear level of active
positive transcription elongation factor b (P-TEFb),
the 7SK small nuclear RNA (snRNA) functions as a
key regulator of RNA polymerase II transcription.
Together with hexamethylene bisacetamide-inducible
proteins 1/2 (HEXIM1/2), the 7SK snRNA sequesters
P-TEFb into transcriptionally inactive ribonucleo-
protein (RNP). In response to transcriptional stimula-
tion, the 7SK/HEXIM/P-TEFb RNP releases P-TEFb to
promote polymerase II-mediated messenger RNA
synthesis. Besides transiently associating with
HEXIM1/2 and P-TEFb, the 7SK snRNA stably inter-
acts with the La-related protein 7 (Larp7) and the
methylphosphate capping enzyme (MePCE). In this
study, we used in vivo RNA–protein interaction
assays to determine the sequence and structural
elements of human 7SK snRNA directing assembly
of the 7SK/MePCE/Larp7 core snRNP. MePCE inter-
acts with the short 50-terminal G1-U4/U106-G111
helix-tail motif and Larp7 binds to the 30-terminal
hairpin and the following U-rich tail of 7SK. The
overall RNA structure and some particular nucleo-
tides provide the information for specific binding of
MePCE and Larp7. We also demonstrate that binding
of Larp7 to 7SK is a prerequisite for in vivo recruit-
ment of P-TEFb, indicating that besides providing sta-
bility for 7SK, Larp7 directly participates in P-TEFb
regulation. Our results provide further explanation
for the frequently observed link between Larp7 muta-
tions and cancer development.
INTRODUCTION
Controlling the elongation capacity of RNA polymerase
II (Pol II) by positive transcription elongation factor b
(P-TEFb) is a fundamental step of eukaryotic transcrip-
tion regulation (1–3). After transcription initiation and
synthesis of the 20–30 nt long 50-terminal RNA sequences,
Pol II is arrested by negative elongation factors (4,5). To
release the promoter proximally paused Pol II and to
couple transcription elongation with pre-messenger RNA
processing, P-TEFb phosphorylates the negative elong-
ation factors and the heptapeptide repeats (YSPTSPS) in
the carboxy-terminal domain of Pol II at serine 2. P-TEFb
is a general and essential transcription factor that is com-
posed of the cyclin-dependent kinase Cdk9 and its regula-
tory subunit cyclin T1 (CycT1) or less frequently CycT2 (6).
The nucleoplasmic level of active P-TEFb is controlled
by the 7SK transcriptional regulatory small nuclear RNA
(snRNA) (7–10). The human 7SK snRNA is an abundant,
331-nt long Pol III-synthesized nucleoplasmic RNA that is
composed of a long 50-terminal, a short 30-terminal and two
internal hairpin domains (11). Together with the homo- or
heterodimer of the hexamethylene bisacetamide-inducible
proteins 1 and 2 (HEXIM1 and HEXIM2), the 7SK
snRNA recruits P-TEFb and inhibits its kinase activity
(12–19). HEXIM1 and HEXIM2 are RNA-binding
proteins, which bind to the 50-terminal hairpin of 7SK
snRNA with great speciﬁcity (13,20,21). The 50-hairpin of
7SK carries two structurally similar HEXIM-binding
motifs, which recruit HEXIM1/2 in a strictly interdepend-
ent manner in living cells (20). A conformational rearrange-
ment induced by 7SK docking enables the C-terminal
inhibitory domain of HEXIM1/2 to interact with the
CycT1 regulatory subunit of P-TEFb and thereby, to
inhibit the kinase activity of Cdk9 (13,15,16,22–24).
Association of 7SK snRNA with HEXIM1/2 and
P-TEFb is a highly dynamic process. It is controlled by a
largely unknown signalling mechanism that adjusts the
nuclear equilibrium of active and inactive P-TEFb to the
actual transcriptional condition of the cell. On transcrip-
tional arrest, the 7SK/HEXIM/P-TEFb transcriptional in-
hibitory small nuclear ribonucleoprotein (snRNP) is
rapidly disassembled to release active P-TEFb and to
promote Pol II transcription (7,8). At the same time, the
free 7SK snRNA associates with a set of heterogeneous
nuclear ribonucleoproteins (hnRNP) proteins, including
hnRNP A1, A2/B1, R and Q (25–27).
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In contrast to the transiently associating HEXIM1/2,
CycT1, Cdk9 and hnRNP proteins, the methylphosphate
capping enzyme (MePCE) (also known as BCDIN3) and
La-related protein 7 (Larp7) (PIP7S) ribonucleoproteins
stably interact with the 7SK snRNA to constitute the
7SK/MePCE/Larp7 core snRNP (28–33). As integral
components of the 7SK snRNP, MePCE and Larp7
provide metabolic stability for the 7SK snRNA. MePCE
has a methyltransferase domain, and it is responsible for
monomethylation of the gamma phosphate of the 50-
terminal guanosine-triphosphate of nascent 7SK snRNA
(30,33). Larp7 belongs to the family of La-related
proteins, and it binds to the 30-terminal U-rich tail of
7SK through its N-terminal La module that is composed
of the conserved La motif and the following RNA recog-
nition motif 1 (RRM1) (28,29,31,32). Diminution of 7SK
snRNA increases the nuclear level of active P-TEFb that
eventually leads to malignant transformation of cultured
mammary epithelial cells (29). Consistent with this, Larp7
mutations or downregulation have been found to promote
gastric and cervical tumorigenesis (34,35).
To understand the structural organization of the 7SK/
MePCE/Larp7 transcriptional regulatory core snRNP, in
this study, we have determined the structural elements of
human 7SK snRNA directing the in vivo binding of
MePCE and Larp7. We have also shown that binding of
Larp7 to the 7SK snRNA is necessary for P-TEFb recruit-
ment, demonstrating that in living cells, the 7SK/MePCE/
Larp7 core snRNP, rather than the 7SK RNA alone,
possesses the capacity to control P-TEFb activity.
MATERIALS AND METHODS
General procedures
Unless indicated otherwise, all techniques used for cloning
of DNA and for manipulating RNA, oligodeoxynu-
cleotides and proteins were performed according to
standard laboratory protocols (36). Oligodeoxynucleotides
were synthesized by Euroﬁns MWG. HeLa and G3H cells
were grown in Dulbecco’s modiﬁed Eagle medium supple-
mented with 10% fetal calf serum (Invitrogen). Expression
plasmids were introduced into HeLa and G3H cells by
using jetPRIME transfection reagent as recommended by
the manufacturer (Ozyme).
Construction and structure of expression plasmids
Construction of the p7SK plasmid designed for transient
expression of human 7SK snRNA has been described (21).
Mutant 7SK expression constructs were generated by
polymerase chain reaction (PCR) ampliﬁcation using mu-
tagenic oligodeoxynucleotide primers and the p7SK
plasmid or its appropriate derivatives as DNA templates.
The p7SKd50h (U6-A101), p7SK50h (U112-C324),
p7SK50h+30h (U116-C295), p7SKd1 (A296-C304
and C320-C324), p7SKd2 (G305-U319), p7SKd3
(A310-G314), p7SKd4 (C320-U321) and p7SKd5
(C102-C114) expression plasmids carried the indicated
internal deletions in the coding region of p7SK. In
the p7SKm1 (A296-A301), p7SKm2 (G302-C304),
p7SKm3 (G322-C324), p7SKm4 (G305-C309), p7SKm5
(G315-U319), p7SKm6 (C320-U321), p7SKm2/3
(G302-C304 and G322-C324), p7SKm4/5 (G305-C309
and G315-U319) and p7SKtag2 (C233-A245) expression
plasmids, the indicated sequences of the coding region of
p7SK were replaced with complementary sequences. The
7SKtag1 construct carried the C108 to G and
111-GUG-113 to ACC nucleotide alterations. The
p7SK30U construct contained the C328 to U point
mutation; otherwise it was identical to p7SKtag1. The
p7SKL1 (A310 to U), p7SKL2 (U311 to A), p7SKL3
(G312 to C), p7SKL4 (U313 to A) and p7SKL5 (G314
to C) plasmids was based on p7SKtag1, but they carried
the indicated nucleotide transversions. The 7SK50hm1
(G2), 7SK50hm2 (A3), 7SK50hm3 (U4), 7SK50hm4
(U106-C108), 7SK50hm5 (A109-G111) and 7SK50hm6
(C103-C105) plasmids were generated through introduc-
tion of complementary nucleotides into the indicated pos-
itions of p7SK50h. To obtain p7SK50h+30hm7
(A310-G314) and p7SK50hm7+30hm7 (G2-U4 and
A310-G314), the indicated sequences (according to the
numbering of wild-type 7SK) of the p7SK50h+30h expres-
sion plasmid were replaced with complementary nucleo-
tides. To generate pU1P-7SKtag2, the 7SK coding region
of the p7SKtag2 expression plasmid was PCR-ampliﬁed
and used to replace the U1 snRNA coding region in the
phU1 expression plasmid (37). To obtain the FL-LARP7
expression construct, the full-length complementary DNA
of human Larp7 was cloned by reverse transcriptase-PCR
and cloned into the p3XFLAG-CMV-10 expression vector
that encodes three adjacent Flag epitopes upstream of the
inserted Larp7 complementary DNA (Sigma). The
pMePCE-FL expression plasmid was purchased from
Origene (RC200948).
Immunoprecipitation
Extract preparation from transfected or non-transfected
HeLa and G3H cells and immunoprecipitation (IP) of en-
dogenous Larp7, CycT1 and La or ectopically expressed
MePCE-FL, FL-Larp7 and HA-CycT1 proteins were per-
formed as described before (21,26). Antibodies speciﬁc for
the Flag (Sigma, M2) and HA (Roche, 12CA5) epitope
tags or for the human Larp7 (Aviva Systems Biology,
ARP40847-P050), La (OriGene, TA500406) and CycT1
(Abcam, ab2098) proteins have been purchased.
Polyclonal anti-2,2,7-trimethyl-G (TMG) antibody was
kindly provided by Dr. R. Lu¨hrmann (Max Planck
Institute for Biophysical Chemistry, Go¨ttingen,
Germany).
RNA analysis
Isolation of RNA from transfected or non-transfected
HeLa and G3H cells was performed by using the
guanidinium thiocyanate/phenol-chloroform extraction
procedure (38). From the pellet of IP reactions, RNA
was isolated by phenol–chloroform extraction. RNAs
co-immunoprecipitated with Larp7 and MePCE were 30
end-labelled with [50-32P]pCp and T4 RNA ligase and
fractionated on a 6% sequencing gel (39). For northern
blot analysis, RNAs were separated on a 6% denaturing
gel and electroblotted onto a Hybond-N nylon membrane
(Amersham Biosciences). The ﬁlters were probed with
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50-terminally labelled oligonucleotides complementary to
the human 7SK, U6 and U4 snRNAs. To generate
sequence-speciﬁc antisense RNA probes for mapping of
transiently expressed mutant 7SK RNAs, the correspond-
ing 7SK expression plasmids were digested with PstI and
used as templates for in vitro transcription with T7 RNA
polymerase in the presence of [a-32P]CTP (3000Ci/mmol).
RNase A/T1 protection analysis has been described (38).
RESULTS
HeLa cellular RNAs associated with Larp7 and MePCE
Previous works demonstrated that Larp7 and MePCE
bind to the 7SK and U6 snRNAs, but it remained
unclear whether they possess other target RNAs in the
cell (29,31,32). To deﬁne the complete repertoire of
human HeLa cellular RNAs interacting with Larp7 and
MePCE, endogenous Larp7 and transiently expressed
Flag-tagged MePCE were immunoprecipitated with
Larp7- and Flag-speciﬁc antibodies. RNAs co-puriﬁed
with Larp7 and MePCE-FL were 30 end-labelled with
[50-32P]pCp and T4 RNA ligase and separated on a
sequencing gel (Figure 1A). IP of Larp7 recovered the
7SK snRNA but, in contrast to a previous report (31),
failed to pull down signiﬁcant amount of U6 snRNA
(lane 2). On the other hand, MePCE-FL showed a
strong in vivo association with both 7SK and U6 and
another HeLa RNA that, based on its gel electrophoretic
mobility, was predicted to be the U4 spliceosomal snRNA
that is known to form a heterodimer with U6 (lane 4).
Northern blot analysis conﬁrmed the identity of all
Larp7- and MePCE-associated RNAs and further
corroborated that Larp7 interacts with only a small
fraction (1–2%) of HeLa U6 snRNA and that MePCE
associates with not only the U6 mono-snRNP but also
the U6/U4 di-snRNP (Figure 1B). To further assess the
extent of Larp7 association with 7SK and U6 snRNAs, we
measured the 7SK and U6 levels in HeLa cell extracts
before and after immunodepletion of Larp7 (Figure 1C).
Northern blot analysis demonstrated that depletion of
98% of Larp7 removed >96% of 7SK from the
extract, but it had no detectable effect on the level of
U6. Thus, we concluded that human MePCE is an
integral component of both 7SK and U6 snRNPs,
whereas Larp7 binds predominantly, if not exclusively
(see ‘Discussion’ section), to the 7SK snRNP.
The 30-hairpin and the following oligouridylate tail of 7SK
work together in Larp7 binding
It has been demonstrated that under in vitro conditions,
Larp7 binds to the 30-terminal U-rich tail of 7SK through
its La module (28,29,32). However, it remained unknown
how Larp7 can distinguish between 7SK and other Pol
III-transcripts, which also carry oligouridylate 30-termini.
To deﬁne 7SK elements providing speciﬁcity for Larp7
binding, we tested the in vivo Larp7-binding capacity of
internally truncated 7SK RNAs, which were transiently
expressed in HeLa cells by using the p7SK expression
vector (21) (Figure 2A). After extract preparation, Larp7
was immunoprecipitated, and co-puriﬁcation of the
expressed mutant 7SK test RNAs and, as a positive
control, the endogenous HeLa 7SK RNA was monitored
by northern blot analysis. As expected, removal of the 50-
terminal hairpin of 7SK did not inﬂuence the
Larp7-binding capacity of the resulting 7SKd50h RNA
(lane 3). However, the 30-terminally truncated 7SK50h
RNA failed to interact with Larp7, although it retained
the wild-type 30-terminal U-rich sequence (UUUCUUU)
of 7SK (lane 6). Insertion of the wild-type 30-hairpin of
7SK before the U-rich tail of 7SK50h fully restored the
Larp7-binding ability of the resulting 7SK50h+30h RNA
(lane 9). These results demonstrated that all RNA
elements required for speciﬁc and efﬁcient in vivo
binding of Larp7 are located in the 30-hairpin and the
following U-rich tail of human 7SK snRNA.
To conﬁrm the importance of the 30-hairpin of 7SK for
Larp7 binding, we investigated the in vivo association of
Figure 1. In vivo association of Larp7 and MePCE with human cellular
RNAs. (A) Detection of RNAs associated with Larp7 and MePCE.
HeLa RNAs co-immunoprecipitated with endogenous Larp7 and tran-
siently expressed Flag-tagged MePCE were 30-terminally labelled and
separated on a 6% sequencing gel. Control IP reactions performed
from non-transfected cells (NT) or without antibody (Cont IP) are
shown. Lane M, size markers in nucleotides. (B) Northern blot
analysis. HeLa RNAs co-immunoprecipitated with Larp7 and
MePCE-FL were separated on a sequencing gel, electroblotted onto a
Nylon membrane and probed with oligodeoxynucleotide probes speciﬁc
for the 7SK, U4 and U6 snRNAs. RNAs isolated from cell extracts
(Ext) and pellets of control IPs (Cont IP) were also analysed. (C) The
majority of HeLa 7SK snRNA is associated with Larp7. The levels
of Larp7, 7SK and U6 were determined by western and northern
blot analyses in Larp7-depleted (a-Larp7) and mock-depleted (Cont
IP) extracts.
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HeLa Larp7 with transiently expressed 7SK RNAs
carrying partially truncated 30-hairpins (Figure 2B).
Northern blot analysis of RNAs co-immunoprecipitated
with Larp7 revealed that deletion of the basal helix region
(d1), the terminal stem-loop (d2) or the terminal loop (d3)
of the 30-hairpin of 7SK fully abolished the in vivo associ-
ation of the mutant 7SK RNAs with Larp7 (lanes 3, 6 and
9). Likewise, deletion of the C320-U321 internal bulge nu-
cleotides (d4) fully eliminated the in vivo Larp7-binding
ability of the resulting 7SK50h+30hd4 RNA (lane 12). It
is noteworthy that all 7SK RNAs lacking Larp7-binding
ability showed a reduced accumulation compared with
RNAs carrying the wild-type 30-terminal hairpin-tail
region. This further supports the notion that Larp7
controls the cellular stability of 7SK snRNA.
To assay the functional interdependence of the 30-
terminal U-rich tail and the preceding 30-hairpin, these
two elements of 7SK were separated by a 20-nt long
random sequence in the 7SKext test RNA (Figure 2C).
When expressed in HeLa cells, the accumulating 7SKext
RNA failed to efﬁciently interact with Larp7 (lane 3).
However, insertion of another copy of the 7SK 30-hairpin
before the U-rich terminal sequence of 7SKext fully restored
the Larp7-binding activity of the resulting 7SK2h RNA
(lane 6). These results demonstrated that the 30-terminal
hairpin and the following U-rich tail of 7SK snRNA
together constitute the docking site for Larp7.
7SK RNA elements supporting speciﬁc binding of Larp7
To further dissect the RNA structural determinants of
Larp7 binding to 7SK, a series of sequence alterations
were introduced into the 30-terminal hairpin of 7SK
snRNA (Figure 3A). The altered 7SK RNAs were ex-
pressed in HeLa cells, and their association with Larp7
was assayed. To distinguish between transiently expressed
mutant and endogenous 7SK RNAs, HeLa RNAs
co-immunoprecipitated with Larp7 were mapped by
RNase A/T1 protection using RNA probes complemen-
tary to the test RNAs. The protected probe RNAs were
separated on a sequencing gel. Alteration of the
single-stranded A296-A301 sequence preceding the
30-hairpin of 7SK failed to alter the Larp7-binding
ability of the mutant 7SKm1 RNA. In contrast, disruption
of the short proximal helix (Hp, 7SKm2 and 7SKm3) or
the distal helix (Hd, 7SKm4 and 7SKm5) of the 30-hairpin
Figure 2. 7SK elements required for in vivo binding of Larp7. (A) Association of transiently expressed truncated 7SK RNAs with HeLa Larp7.
Organization of the p7SK expression construct with the relevant sites is shown. Predicted schematic structures of the expressed internally truncated
7SK RNAs are shown. Co-IP of 7SK test RNAs and the endogenous HeLa 7SK snRNA with Larp7 was monitored by northern blot analysis.
RNAs from cell extracts (Ext) and control IPs (no antibody) were also analysed. (B) Association of HeLa Larp7 with transiently expressed 7SK
RNAs carrying truncated 30-hairpins. Structure of the 30-hairpin of 7SK test RNAs is shown. Deleted nucleotides are boxed (d1 and d4) or they are
indicated by arrows (d2 and d3). Transiently expressed 7SKd1, 7SKd2, 7SKd3 and 7SK50h+30hd4 RNAs were co-immunoprecipitated with Larp7
and analysed by northern blotting. Endogenous 7SK is indicated. (C) The 30-terminal hairpin and the following U-rich tail of 7SK work together in
Larp7 binding. Schematic structures of the 30-terminal regions of 7SKext and 7SK2h RNAs are shown. Dashed lines indicate random sequences
inserted between the 30-hairpin and the terminal U-rich tail. Co-IP of transiently expressed 7SKext and 7SK2h RNAs with Larp7 was measured by
northern blot analysis.
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largely inhibited or completely abolished the
Larp7-binding capacity of the Hp- and Hd-mutant
RNAs, respectively. Restoration of the proximal and
distal helices through combining the m2 and m3 or the
m4 and m5 mutations fully re-established the in vivo inter-
action of 7SKm2/3 and 7SKm4/5 RNAs with Larp7,
indicating that these helix structures themselves, rather
than their nucleotide compositions, are important for
Larp7 binding. Substitution of the C320-U321 bulge nu-
cleotides had no signiﬁcant effect on the Larp7-binding
activity of 7SKm6 RNA. This indicates that the nucleotide
composition of the C320-U321 internal bulge is not
crucial, although its presence is essential for Larp7
binding (see Figure 2B). Replacement of the A310-G314
terminal loop sequence with its complementary sequence
fully eliminated the in vivo interaction of the altered
7SKm7 RNA with Larp7, demonstrating that the
nucleotide composition of the A310-G314 terminal loop
is important for Larp7 binding.
To deﬁne the contribution of each terminal loop nucleo-
tide to Larp7 binding, systematic base mutations (L1–L5)
were introduced into terminal loop of the 7SKtag1 RNA
that carried other neutral nucleotide alterations (tag1) to
promote sequence-speciﬁc RNase mapping (Figure 3B).
The 7SKtag1 RNA co-immunoprecipitated with Larp7
conﬁrming that the tag1 sequence had no effect on
Larp7 binding. The A310-U (L1), U311-A (L2) and
G314-C (L5) nucleotide transversions failed to signiﬁ-
cantly alter the in vivo interaction of the expressed
7SKL1, 7SKL2 and 7SKL5 RNAs with HeLa Larp7.
However, replacement of the G312-C (L3) and U313-A
(L4) loop residues fully abolished and largely reduced
the Larp7-binding capacity of the mutant 7SKL3 and
7SKL4 RNAs, respectively. We concluded that the G312
Figure 3. In vivo association of Larp7 with mutant 7SK RNAs. (A) Structural requirements of Larp7 binding to the 30-hairpin of 7SK. Mutant 7SK
RNAs carrying sequence alterations (in shaded boxes) in their 30-hairpin were expressed in HeLa cells, and their co-IP with endogenous Larp7 was
measured by RNase A/T1 mapping. For other details, see the legend to Figure 2. (B) Mutational analysis of the terminal loop of the 30-hairpin of
7SK. Association of HeLa Larp7 with transiently expressed 7SKtag1 RNAs carrying the L1 to L5 nucleotide alterations was investigated by co-IP
and RNase A/T1 mapping. (C) The C328 residue in the 30-terminal U-rich stretch of 7SK is not required for Larp7 binding. Co-IP of transiently
expressed 7SKtag1 and 7SK30U RNAs with Larp7 was assayed by RNase A/T1 mapping.
4690 Nucleic Acids Research, 2013, Vol. 41, No. 8
 at Szegedi Tudom
anyegyetem
 / U
niversity of Szeged on N
ovem
ber 14, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
nucleotide is absolutely required, and the following U313
residue is important for efﬁcient in vivo binding of Larp7.
The 30-terminal oligouridylate tail of human 7SK
snRNA is interrupted by a cytidine (C328) that, in prin-
ciple, could contribute to the speciﬁc binding of Larp7
(Figure 3C). Conversion of the C328 residue to uridine,
however, failed to alter the Larp7-binding capacity of the
resulting 7SK30U RNA, excluding a speciﬁc role for C328
in Larp7 binding. Taken together, the experiments pre-
sented thus far demonstrate that the Larp7-binding
elements are conﬁned to the 30-terminal U-rich tail and
the preceding short 30-hairpin of 7SK. The overall struc-
ture of the 30-hairpin and the G312 and U313 residues in
its terminal loop provide the speciﬁcity for Larp7 binding.
MePCE binds to the basal part of the 50-hairpin of
7SK snRNA
To determine the MePCE-binding region of 7SK, we ﬁrst
investigated the in vivo association of transiently expressed
MePCE-FL with the internally truncated 7SK50h+30h,
7SK50h and 7SKd50h RNAs (for RNA structures, see
Figure 2A). On IP of MePCE-FL, northern blot analysis
detected all test RNAs in the pellets of the IP reactions
(Figure 4A, lanes 4, 8 and 12). This suggested that
MePCE-FL binds to the basal part of the 50-hairpin
and/or to the 50-terminal gamma-monomethyl-G cap of
7SK snRNA, as only these elements were common in
three test RNAs. To conﬁrm this assumption and to
further dissect the MePCE-binding elements of 7SK,
mutant versions of the 7SK50h RNA were expressed in
HeLa cells, and their association with MePCE-FL was
assayed (Figure 4B). Disruption of the short G1-A3/
U106–C108 terminal helix by introducing the G2-C
(50hm1) or A3-U (50hm2) nucleotide transversions or
replacing the U106-C108 sequence with its complementary
sequence (50hm4) disrupted the association of 7SK50hm1,
7SK50hm2 and 7SK50hm4 RNAs with MePCE-FL (lanes
4, 6 and 10). Alteration of the U4 internal loop nucleotide
(50hm3) and the A109-G111 single-stranded sequence fol-
lowing the G1-A3/U106–C108 basal helix highly reduced
or fully abolished MePCE-FL association with the mutant
7SK50hm3 and 7SK50hm5 RNAs, respectively (lanes 8 and
12). In contrast, replacement of the C103-C105 internal
loop nucleotides had no detectable effect on the
MePCE-binding capacity of 7SK50hm6 (lane 14). These
results demonstrated that the 50-terminal G1-A3/
U106-C108 helix and the ﬂanking U4 and A109-G111
single-stranded nucleotides direct the in vivo binding of
MePCE to the 7SK snRNA.
MePCE can bind to 7SK in a cap-independent manner
We tested whether the 50-terminal gamma-monomethyl
cap could contribute to the MePCE-binding activity of
7SK snRNA. The 7SK coding region carrying internal
marker sequence (tag2) was placed under the control of
the promoter and terminator of the Pol II-speciﬁc human
U1 snRNA gene (Figure 5A). The 50-termini of nascent
Pol II transcripts acquire co-transcriptionally the
Figure 4. 7SK elements supporting in vivo MePCE binding. (A) MePCE binds to the basal stem region of the 50-hairpin of 7SK. Truncated
7SK50h+30h, 7SK50h and 7SKd50h RNAs were co-expressed with Flag-tagged MePCE (MePCE-FL) as indicated above the lanes. MePCE-FL
was immunoprecipitated, and co-precipitation of mutant and wild-type 7SK RNAs was monitored by northern blotting. (B) Sequence requirements
of MePCE binding to the 50-hairpin of 7SK. Co-IP of transiently expressed MePCE-FL with mutant 7SK50h RNAs carrying the indicated nucleotide
alterations (shaded boxes) was tested by northern blotting.
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7-methyl-G primary cap that is further methylated to
TMG in snRNAs (40,41). On transfection of the Pol
II-speciﬁc pU1P-7SKtag2 and the control Pol III-speciﬁc
p7SKtag2 expression plasmids into HeLa cells, the
7SKtag2 RNA accumulated in both cell lines (lanes 1
and 3). Incubation of the transfected cells with
a-amanitin abolished the U1 promoter-dependent expres-
sion of 7SKtag2 (lane 4) but failed to inhibit 7SKtag2
expression from the Pol III-speciﬁc 7SK promoter
(lane 2). Moreover, a TMG-speciﬁc antibody efﬁciently
and speciﬁcally recovered the 7SKtag2 RNA synthesized
from the U1 promoter but failed to recognize the endogen-
ous HeLa 7SK snRNA (lane 7). Thus, we concluded that
the pU1P-7SKtag2 expression vector was transcribed by
Pol II, and the expressed 7SKtag2 RNA carried a TMG
cap.
Next, we assayed the association of the Pol
II-synthesized TMG-capped 7SKtag2 RNA with transi-
ently co-expressed MePCE-FL. Similar to the endogenous
monomethyl-capped 7SK snRNA, the ectopically ex-
pressed TMG-capped 7SKtag2 RNA interacted with
MePCE-FL (Figure 5B, lane 4), suggesting that the
natural monomethyl cap of 7SK snRNA is not required
for in vivo MePCE binding. We found that the Pol
II-synthesized 7SKtag2 RNA also associated with transi-
ently co-expressed FL-Larp7 (lane 8). On RNase-
mediated 7SK hydrolysis, the Larp7 and MePCE
snRNP proteins remain associated with each other,
indicating that Larp7 and MePCE form a direct contact
in the 7SK snRNP (28,33) (our unpublished results).
Therefore, it is conceivable that Larp7 bound to the 30-
terminal region of the TMG-capped 7SK RNA could
recruit MePCE to the 7SK snRNP without forming a
direct 7SK-MePCE contact. To exclude this possibility,
an altered version of the 7SK50h+30h RNA carrying the
m7 30-hairpin loop mutations, which fully abolish Larp7
binding, was expressed under the control of the U1
promoter in HeLa cells also expressing MePCE-FL
(Figure 5C). Similar to the endogenous 7SK snRNA, the
Pol II-synthesized 7SK50h+30hm7 RNA efﬁciently inter-
acted with MePCE-FL (lane 3) but failed to bind Larp7
(data not shown, see Figure 3A). Thus, we concluded that
the gamma-monomethyl cap of human 7SK snRNA is
dispensable for in vivo MePCE binding.
Larp7 promotes MePCE recruitment to 7SK
To further explore the functional importance of the
observed interaction of Larp7 and MePCE (28,33) (our
unpublished results), we ﬁrst tested the in vivo association
of MePCE with an internally truncated 7SK RNA,
7SKd5, that lacked functional MePCE docking site, but
carried the wild-type Larp7-binding element (Figure 6A).
The 7SKd5 RNA was expressed under the control of the
cognate 7SK promoter in HeLa cells also expressing
MePCE-FL. IP of MePCE-FL recovered both the transi-
ently expressed 7SKd5 RNA and the endogenous 7SK
snRNA (lane 4). This strongly suggested that MePCE
can associate with 7SK RNA lacking a functional
MePCE-binding site through interacting with Larp7.
Figure 5. Cap independent in vivo association of 7SK snRNA with
MePCE. (A) Pol II-mediated expression of 7SK snRNA. Schematic
structure of the pU1P-7SKtag2 expression construct with the
promoter (U1 PROM) and terminator (U1-30) of the human U1
snRNA gene is shown. Nucleotide alterations in the 7SK-coding
region (tag2) are indicated. HeLa cells transfected with
pU1P-7SKtag2 or p7SKtag2 were incubated with (+) or without ()
a-amanitin (a-ama). Accumulation of 7SKtag2 RNAs was measured by
RNase A/T1 mapping. RNAs extracted from cells harbouring the
pU1P-7SKtag2 plasmid (Ext) were reacted with an anti-trimethyl-G
antibody (a-TMG). (B) Pol II-synthesized 7SK RNA associates with
both MePCE and Larp7. Extracts (Ext) prepared from HeLa cells
transfected with the indicated combination of the pU1P-7SKtag2,
pMePCE-FL and pLARP-FL expression plasmids were subjected to
IP with anti-Flag antibody. Recovery of 7SKtag2 RNA was monitored
by RNase mapping. (C) In vivo association of MePCE with Pol
II-synthesized 7SK RNA lacking Larp7-binding capacity. Schematic
structure of the 7SK50h+30hm7 RNA with the m7 nucleotide alter-
ations is shown. Co-IP of transiently expressed 7SK50h+30hm7 RNA
with MePCE-FL was monitored by northern blot analysis.
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To conﬁrm this notion, we investigated the in vivo as-
sociation of MePCE and Larp7 with two altered versions
of the 7SK50h+30h RNA (Figure 6B). The 7SK50hm7+30h
RNA carried the 2-GAU-4 to CUA (50hm7) sequence al-
teration, which eliminates MePCE binding to its 50-hairpin
(see Figure 4B). The 7SK50hm7+30hm7 RNA, in addition
to the 50hm7 mutation, also contained the 30hm7 loop
mutation, which prevents Larp7 binding (see Figure 3A).
Consistent with the observed association of 7SKd5 with
both Larp7 and MePCE, the transiently expressed
7SK50hm7+30h RNA co-puriﬁed with both endogenous
Larp7 and ectopically expressed MePCE-FL (Figure 6B,
lanes 3 and 7). However, disruption of the Larp7-binding
capacity of 7SK50hm7+30hm7 also eliminated its
interaction with MePCE-FL (lanes 10 and 14), providing
further support to the idea that recruitment of MePCE to
7SK RNAs lacking an active MePCE-binding
motif occurred through forming an interaction with
Larp7.
7SK mutations interrupting Larp7 binding also abolish
P-TEFb recruitment
We have previously observed that destruction of the
30-terminal hairpin abolishes the in vivo P-TEFb-binding
activity of 7SK snRNA (21). Demonstration that the
30-hairpin of 7SK plays a crucial role in Larp7 binding
raised the possibility that the 7SK-associated Larp7
protein rather than the RNA 30-hairpin itself supports
the in vivo recruitment of P-TEFb to the 7SK snRNP.
To test this idea, we investigated the in vivo association
of P-TEFb with the 7SKext RNA that, although carried
the wild-type 30-hairpin, failed to efﬁciently bind Larp7
owing to its misplaced U-rich 30-tail (see Figure 2C).
The 7SKext RNA was transiently expressed in HeLa-
based G3H cells, which stably express an HA-tagged
version of CycT1 (42) (Figure 7A, lane 1). IP of
HA-CycT1 failed to efﬁciently recover 7SKext, although
it pulled down the endogenous 7SK snRNA (lane 3). This
strongly supported the notion that binding of Larp7 to
7SK is a prerequisite for P-TEFb recruitment.
Substitution of the terminal loop sequence of the 30-
hairpin of 7SK abolishes both P-TEFb and Larp7
binding (21) (Figure 3). As our current analysis identiﬁed
the G312 and U313 loop nucleotides as crucial structural
determinants for Larp7 binding (Figure 3B), we also
tested the importance of these residues for P-TEFb re-
cruitment (Figure 7B). HeLa endogenous CycT1 was
immunoprecipitated, and co-puriﬁcation of transiently ex-
pressed 7SKtag1 RNAs carrying the L1, L2, L3, L4 and
L5 loop mutations was measured by RNase mapping. As
it was observed for Larp7, CycT1 showed a strong asso-
ciation with the expressed 7SKL1, 7SKL2 and 7SKL5
RNAs (lanes 6, 9 and 18). However, the G312-C (L3)
and the U313-A (L4) loop mutations, which abolished
and reduced Larp7-binding, respectively, also eliminated
and inhibited the CycT1-binding ability of the mutant
7SKL3 and 7SKL4 RNAs (lanes 12 and 15). These
results conﬁrmed that binding of Larp7 to the 30-terminal
Figure 6. In vivo interaction of Larp7 and MePCE. (A) MePCE can associate with 7SK lacking functional MePCE-binding site. Extracts (Ext)
prepared from HeLa cells transfected with the indicated combination of pMePCE-FL and p7SKd5 were reacted with an anti-Flag antibody.
Recovery of 7SKd5 RNA was measured by northern blot analysis. (B) Larp7 can tether MePCE to the 7SK snRNP lacking functional
MePCE-binding site. Nucleotide alterations (50hm7 and 30m7) introduced into the p7SK50h+30h expression construct are indicated in shaded
boxes. HeLa cells were transfected with the p7SK50hm7+30h, p7SK50hm7+30hm7 and pMePCE-FL expression constructs as indicated. Co-IP of
endogenous 7SK snRNA and transiently expressed 7SK50hm7+30h and 7SK50hm7+30hm7 RNAs with MePCE-FL and Larp7 was monitored by
northern blot analysis.
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hairpin-tail region of human 7SK snRNA is a prerequisite
for in vivo recruitment of P-TEFb.
The La-associated fraction of 7SK does not interact with
Larp7, HEXIM1 and P-TEFb
The 30-terminal oligouridylate tail of the newly synthesized
7SK snRNA associates with the La protein that provides
stability for the nascent RNA (43,44). To further conﬁrm
that docking of Larp7 is fundamental for subsequent
P-TEFb recruitment, we tested whether the La-associated
fraction of 7SK snRNA is able to interact with P-TEFb
(Figure 8). On IP of HeLa La protein with a speciﬁc
antibody, the 7SK snRNA was readily detected in the
pellet (lane 3). However, apart from transiently expressed
MePCE-FL, other components of the 7SK negative tran-
scriptional regulatory snRNP, including Larp7, HEXIM1
and CyT1, were not detectable in the pellet of the IP
reaction. Moreover, hnRNP A1, the most abundant com-
ponent of the 7SK/hnRNP particle (26,27), also failed to
co-purify with the immunoprecipitated La protein. These
observations conﬁrmed that the La-associated fraction of
human 7SK RNA is inactive in transcription regulation,
and they suggested that replacement of La protein with
Larp7 is a prerequisite for conversion of the native 7SK
RNA into functional transcriptional regulatory snRNA.
DISCUSSION
P-TEFb is a general transcription factor that regulates the
processivity of Pol II and thereby controls global gene
expression, cell growth and development. The nuclear
activity of P-TEFb is regulated by the 7SK core snRNP
that is composed of the 7SK snRNA and the MePCE and
Larp7 snRNP proteins. In this study, we performed in vivo
RNA–protein binding experiments to deﬁne the structural
elements of human 7SK snRNA, which direct the in vivo
assembly of functionally active 7SK/MePCE/Larp7 tran-
scriptional regulatory snRNP.
Early in vitro and in vivo RNA structure probing experi-
ments revealed that the human 7SK snRNA is composed
of four major hairpin domains (11) (Figure 9). Functional
analysis of compensatory base changes introduced into the
predicted double-stranded regions of the 50- and 30-
hairpins of human 7SK snRNA largely conﬁrmed the
Figure 8. Co-puriﬁcation of HeLa 7SK snRNP proteins with La protein.
HeLa La protein was immunoprecipitated with a La-speciﬁc antibody
and co-puriﬁcation of endogenous 7SK snRNA, Larp7, HEXIM1,
CycT1, hnRNP A and transiently expressed MePCE-FL was monitored.
Figure 7. Binding of Larp7 to the 7SK snRNA is essential for P-TEFb recruitment. (A) Separation of the 30-terminal hairpin and the U-rich tail of 7SK
by sequence insertion inhibits P-TEFb binding. The 7SKext RNA (see Figure 2C) was transiently expressed in G3H cells expressing HA-CycT1. After
extract preparation, HA-CycT1 was immunoprecipitated (a-HA), and co-puriﬁcation of 7SKext and wild-type 7SK RNAs was tested by northern
blotting. (B) The G312 and C313 loop nucleotides are important for P-TEFb binding. 7SKtag1 RNAs lacking or carrying the L1, L2, L3, L4 and L5
nucleotide transversions (see Figure 3B) were expressed in HeLa cells, and their co-IP with endogenous CycT1 was measured by RNase mapping.
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correctness of the proposed 2D 7SK structure (20,21) (this
study). The 50- and 30-hairpin regions of 7SK RNAs
derived from evolutionarily distant species show signiﬁ-
cant structural conservation, pointing to the functional
importance of these elements (20) (our unpublished
data). Indeed, we demonstrated that all elements directing
the in vivo assembly of the 7SK/MePCE/Larp7/HEXIM/
P-TEFb transcriptional regulatory snRNP are located in
the 50- and 30-terminal hairpin regions of human 7SK
snRNA (21) (Figure 9).
MePCE and 7SK co-IP experiments demonstrated that
the short 50-terminal G1-A3/U106-C108 helix and the
ﬂanking unpaired U4 and 109-AUG-11 nucleotides
provide the structural information for speciﬁc binding of
MePCE (Figure 4). Besides being integral component of
the 7SK snRNP, MePCE methylates the gamma-
phosphate of the 50-terminal guanosine-triphosphate of
the newly synthesized 7SK snRNA (30,33). Early in vitro
RNA methylation studies demonstrated that monomethyl
capping of the U6 and 7SK snRNAs depends on their
50-terminal stem–loop structures and the following
single-stranded sequences, which, in fact, show a simi-
larity in U6 and 7SK snRNAs (45,46). This suggests
that 7SK capping and 7SK/MePCE assembly are
directed by the same or largely overlapping RNA sig-
nals and also explains the observed interaction of
MePCE with both 7SK and U6 snRNAs (Figure 1). The
gamma-monomethyl cap is not required for stable associ-
ation of MePCE with mature 7SK snRNA; it
likely protects 7SK from exonucleolytic degradation
(Figure 5B).
All RNA elements directing in vivo Larp7 binding are
conﬁned to the 30-terminal A301-U331 hairpin-tail region
of 7SK snRNA (Figure 2). Although Larp7 shows a
strong in vitro afﬁnity for oligouridylate sequences (32),
the U-rich tail of 7SK alone is unable to support the
in vivo binding of Larp7. The U-rich terminal sequence,
the stem–bulge–stem–loop structure of the preceding
30-hairpin and the G312 and U313 terminal loop nucleo-
tides together constitute the docking surface speciﬁc for
Larp7 (Figure 3). Partial NMR and crystal structures of
another member of the Larp7 family, the Tetrahymena
p65 telomerase RNP protein, revealed that the
C-terminal domain of p65 forms an atypical RRM,
termed xRRM2, which speciﬁcally interacts with the 30-
terminal hairpin of Tetrahymena telomerase RNA (47). It
has been proposed that La and Larp7 proteins follow a
similar strategy for binding substrate RNAs. The
N-terminal La motif and the following RRM1 of La
and Larp7 proteins bind cooperatively to the 30-terminal
oligouridylate tail of the substrate RNA (44). This inter-
action positions their C-terminal domains, which carry the
common xRRM2 cryptic RRM to speciﬁcally interact
with the 30-terminal hairpin of the target RNA (47).
Consistent with this model, mutant human Larp7
proteins lacking their C-terminal regions are unable to
bind 7SK in vitro (29). Our co-IP assays showed that
HeLa Larp7 recognizes the 7SK snRNA with great speci-
ﬁcity (Figure 1). The observed minor Larp7/U6 associ-
ation likely represents non-speciﬁc interaction of Larp7
with U6-bound MePCE. Supporting this hypothesis, in
contrast to endogenous Larp7, transiently overexpressed
Larp7 shows a high level of apparently non-speciﬁc asso-
ciation with HeLa U6 snRNA (31) (our unpublished
data).
Successful monomethyl capping of in vitro synthesized
mammalian 7SK, U6, B2 and plant U3 RNAs in cell
extracts and efﬁcient incorporation of Pol II-synthesized
TMG-capped 7SK RNA into 7SK/MePCE/Larp7 snRNP
demonstrate that under particular conditions, MePCE
function can be uncoupled from Pol III transcription
(48–50) (Figure 5). However, several lines of evidence
indicate that in living cells MePCE-mediated 7SK
capping is functionally linked to Pol III transcription.
All known RNAs carrying gamma-monomethyl-cap,
such as eukaryotic U6 and 7SK snRNAs and rodent B2
RNA, are synthesized by Pol III (50–53). Even more tell-
ingly, the U3 snoRNA, that is synthesized by Pol II and
capped with a TMG cap in most eukaryotes, is a Pol III
product in plants, and it carries a gamma-monomethyl cap
(50,54,55). Thus, evolutionarily switching of the polymer-
ase speciﬁcity of the U3 gene from Pol II to Pol III is
accompanied with monomethyl capping of the RNA
product. Finally, chromatin IP studies documented a
speciﬁc enrichment of MePCE on the promoter region
of human 7SK gene, providing further support to the
notion that in vivo capping of 7SK snRNA is linked to
Pol III transcription (33).
Similar to other nascent Pol III transcripts, the terminal
oligouridylate tail of the newly synthesized 7SK RNA
recruits the stabilizing La protein (43). IP of HeLa La
protein recovered the 7SK snRNA and MePCE, but it
failed to pull down other components of the 7SK tran-
scriptional regulatory snRNP (Figure 8). This suggests
Figure 9. Proposed schematic structure of the 7SK transcriptional
regulatory snRNP. Structure of the 7SK snRNA has been adopted
from (11). The 7SK elements directing HEXIM1 binding have been
reported earlier (20,21).
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that the La protein associated with nascent 7SK prevents
premature assembly of the 7SK/HEXIM/P-TEFb
negative transcriptional regulatory snRNP. The observed
co-puriﬁcation of MePCE with La might indicate that
MePCE binds already to the La-associated fraction of
7SK and/or U6. It has been reported that
methyl-phosphate capping largely reduces the afﬁnity of
U6 and B2 RNAs to the La protein (56). Hence, binding
of MePCE to the nascent 7SK/La RNP and monomethyl
capping of 7SK might promote the replacement of La with
Larp7.
Although MePCE and Larp7 likely interact in the
mature 7SK snRNP (33) (our unpublished data), they
can bind to the 7SK snRNA independently from each
other (Figures 4 and 6). Interestingly, Larp7 can tether
MePCE to mutant 7SK RNAs lacking functional
MePCE-binding sites, but on the contrary, MePCE is
unable to recruit Larp7 to 7SK RNAs missing Larp7-
binding ability. A possible explanation of these seemingly
contradictory observations could be that binding of Larp7
to 7SK increases its afﬁnity to MePCE. Indeed, in vitro
interaction of Larp7 and MePCE is fully dependent on the
presence of the 7SK snRNA (28). This could also explain
the observed weak afﬁnity of HeLa Larp7 to MePCE
associated with U6. On the other hand,
7SK-independent Larp7/MePCE heterodimer formation
would inhibit the methylphosphate capping activity of
nuclear MePCE because binding of Larp7 to MePCE
inhibits its methyltransferase activity (33).
In the test tube, in vitro synthesized 7SK RNA and re-
combinant HEXIM1 proved to be sufﬁcient to recruit
P-TEFb and to inhibit its carboxy-terminal domain
kinase activity (13,15). A conformational rearrangement
induced by 7SK binding enables the acidic C-terminal
domain of HEXIM1/2 to interact with the CycT1
subunit of P-TEFb. Contrary to the fact that HEXIM1/
2 binds exclusively to the 50-hairpin of 7SK, we found
earlier that the 30-hairpin of 7SK is also required for
P-TEFb binding in living cells (20,21). In accordance
with this ﬁnding, here, we demonstrated that in vivo
binding of Larp7 to the 30-hairpin of 7SK is a prerequisite
for in vivo P-TEFb recruitment (Figure 7). Several lines of
evidence suggest that, instead of directly interacting with
7SK, P-TEFb associates with Larp7 bound to the 30-
terminal hairpin of 7SK snRNA. Point mutations abolish-
ing the Larp7-binding capacity of 7SK snRNA also
prevent P-TEFb recruitment (Figure 7B). A mutant 7SK
RNA, 7SKext, although carrying the wild-type 30-hairpin,
but lacking Larp7-binding capacity owing to its misplaced
30-terminal oligouridylate tail fails to bind P-TEFb
(Figure 7A). Nascent 7SK snRNA associated with La,
instead of Larp7, is unable to associate with P-TEFb
(Figure 8). Finally, previous in vitro protein-binding
studies revealed that the C-terminal region of
GST-tagged Larp7 can speciﬁcally interact with Cdk9
(32). Thus, the available data are consistent with a
model in which Larp7, besides binding to the 30 end of
7SK snRNA, also interacts with MePCE and Cdk9, sug-
gesting that Larp7 possesses a more complex role in
7SK-mediated P-TEFb modulation than anticipated
before (Figure 9). Consistent with its central role in
P-TEFb regulation, Larp7 mutations have been frequently
linked to cancer development (34,35). Understanding of
the molecular background of the predicted interaction of
Larp7 and P-TEFb in the 7SK transcriptional regulatory
snRNP will be an important task for the future.
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